SAINT THOMAS HEART OPENS NEW VENTRICULAR ASSIST DEVICE CENTER; ONE OF ONLY 33 DEDICATED CENTERS IN UNITED STATES
NASHVILLE, Tenn. – Jan. 18, 2012 – Saint Thomas Hospital, a member of Saint Thomas Health and a national leader in cardiac care, announced today the opening of the Saint Thomas Heart Ventricular Assist Device (VAD) Center at an invitation only event at LP Field. The center, which is one of only 33 dedicated VAD centers in the United States, will meet the needs of the sickest heart failure patients in Middle Tennessee and southern Kentucky.
For more information about the Saint Thomas Heart VAD Center at Saint Thomas Hospital, visit www.saintthomasheart.com/vad or call 888.655.LVAD (5823). To view a video of an actual VAD implant surgery, visit www.youtube.com/watch?v=OONr8EWswYg.
For more information about the Saint Thomas Heart VAD Center at Saint Thomas Hospital, visit www.saintthomasheart.com/vad or call 888.655.LVAD (5823). To view a video of an actual VAD implant surgery, visit www.youtube.com/watch?v=OONr8EWswYg.
First experience with the new portable extracorporeal membrane oxygenation system cardiohelp for severe respiratory failure in adults
Conclusions: The compact portable ECMO device Cardiohelp is a highly effective method to secure vital gas exchange and to reduce further ventilator-induced lung injury in patients with acute respiratory failure. Crucial technical innovations and ease of device transport and implantation allow location-independent stabilization with consecutive inter-hospital transfer.
Published online before print January 16, 2012, doi:10.1177/0267659111432330Perfusion January 16, 20120267659111432330
Published online before print January 16, 2012, doi:10.1177/0267659111432330Perfusion January 16, 20120267659111432330
Long term Motor and Cognitive Outcomes in Children with CDH...
Conclusions: In the absence of a genetic comorbidity, children with congenital diaphragmatic hernia have a favorable cognitive outcome, but motor outcome may be affected. This needs to be taken into account for parental counseling. Further, long-term neurodevelopmental assessment in children with congenital diaphragmatic hernia is important to provide early therapeutic intervention. Isabell Tureczek MD1, Jon Caflisch MD1, Ulrich Moehrlen MD2, Giancarlo Natalucci MD3, Vera Bernet MD4,†, Beatrice Latal MD MPH1,†DOI: 10.1111/j.1651-2227.2011.02567.x
Acta Pædiatrica © 2011 Foundation Acta Pædiatrica
Acta Pædiatrica © 2011 Foundation Acta Pædiatrica
ARCHIVED
* Single Site VV ECMO in place of ventilatory support...
* Double lumen bi-cava cannula for veno-venous extracorporeal membrane oxygenation as bridge to lung transplantation in non-intubated patient
* The Impact of Extracorporeal Membrane Oxygenation on Survival in Pediatric Patients With Respiratory and Heart Failure
* Antithrombin Replacement During Extracorporeal Membrane Oxygenation
* Improved Survival but Marginal Allograft Function in Patients Treated With Extracorporeal Membrane Oxygenation After Lung Transplantation
* ECMO May Halve Deaths in Patients With Severe H1N1 and ARDS
* Rapid Gas Change During ECMO Linked to Mortality Risk
* Venovenous ECMO Improves Survival for Select Pediatric Patients
* 7-Week Old Boy Gets Artificial Lung at St. Louis HospitalCTSNet News
* EX-Vivo Lung Perfusion, Novel Lung Transplant Trial
CARDIOHELP FDA Clearance for 6 Hour Use
CARDIOHELP
04/2011MAQUET Cardiovascular receives clearance to market the CARDIOHELP System in U.S.
FDA Clearance
Wayne, N.J. - MAQUET Cardiovascular today announced that the U.S. Food and Drug Administration has granted the company 510 (k) clearance to market its CARDIOHELP System in the United States as a cardiac and/or respiratory assist device for up to six hours.
ECMO Advantage Partners with AirMed to Help 3-year-old
AirMed ECMO teams meet miraculous 3 year old(December 8, 2010 - Birmingham) - Alexis Cormier of Hazel Green, Alabama, was born with HLHS, a rare congenital heart defect in which the left side of the heart is severely underdeveloped. It stands for Hypoplastic Left Heart Syndrome. At age 3, she underwent a third surgery to help her symptoms, but after this complicated surgery, her entire heart was damaged beyond repair. She was immediately put on ECMO. ECMO is a highly specialized treatment that stands for Extracorporeal Membrane Oxygenation. It is similar to a heart-lung machine and in effect, it removes the blood from the patient, oxygenates it outside of the body (removing carbon dioxide and adding oxygen) and then replaces it back into the patient. AirMed has the capability of transporting ECMO patients and all of the complicated equipment from one hospital to another’s critical care program. AirMed is one of only a handful of air ambulance programs in the world capable of this type of transport for both pediatric and adult patients.
After being placed on ECMO, Alexis’ hospital in Memphis requested she be moved to Vanderbilt University Hospital in Nashville, and AirMed's ECMO transport team was called intoaction. Only four days after her first ECMO transport flight, it was decided that Alexis needed to be transported again, this time to UAB Hospital in Birmingham, Alabama, where she would receive a Berlin (artificial) heart.
Click HERE for Full Article
After being placed on ECMO, Alexis’ hospital in Memphis requested she be moved to Vanderbilt University Hospital in Nashville, and AirMed's ECMO transport team was called intoaction. Only four days after her first ECMO transport flight, it was decided that Alexis needed to be transported again, this time to UAB Hospital in Birmingham, Alabama, where she would receive a Berlin (artificial) heart.
Click HERE for Full Article
ECMO Advantage Joins AirMed to Provide ECMO Transport
ECMO Advantage partners with AirMed(Birmingham, AL – December 14, 2009) AirMed International, the leading U.S. air ambulance company, announced today that it has entered a cooperative partnership with Tennessee-based ECMO Advantage to provide this life-saving medical equipment onboard its aircraft with ECMO Advantage medical professionals assisting in the transport.
“Many of our customers have requested the transport of patients requiring the support of this highly specialized treatment and equipment during the flight,” said AirMed Executive Vice President Denise Treadwell. “We are very pleased at this new relationship with ECMO Advantage, undoubtedly the leader in this field. This partnership will allow AirMed and ECMO Advantage to provide safe transport of these patients to recognized ECMO Centers around the nation while maintaining quality patient care."
In intensive care medicine, extracorporeal membrane oxygenation (ECMO) is an extracorporeal technique of providing both cardiac and respiratory support oxygen to patients whose heart and lungs are so severely diseased or damaged that they can no longer serve their function. An ECMO machine is similar to a heart/lung machine and is most commonly used in neonatal intensive-care units, for newborns in pulmonary distress, but it is also used for adults that, even with the use of a ventilator, need to be oxygenated until they are able to do the job with out assistance. One of the new uses is in adults with the H1N1 virus. ECMO treatment provides oxygenation until their lung function has sufficiently recovered to maintain appropriate O2 saturation.
About the air ambulance company AirMed International
AirMed International is the country’s leading air ambulance, chosen as exclusive air medical transport for the world-famous Mayo Clinic as well as a preferred carrier for the U.S. Department of Defense. AirMed is CAMTS and EURAMI accredited and operates a fleet of fully customized, fixed-wing aircraft, including the largest medical jet in the U.S., the Hawker 800. AirMed's six strategic bases of operations in Alabama, Hawaii, Minnesota, Ohio, and internationally in Beijing and Hong Kong, provide advantageous geographic coverage and rapid dispatch. AirMed International is the two-time recipient of the International Travel Insurance Journal’s “Air Ambulance of the Year,” and also created weatherturndown.com, an industry-wide website promoting air medical safety across the country. For more information, visit www.airmed.com or call 205-443-4880.
About ECMO Advantage
ECMO Advantage Corp brings a wealth of knowledge to the partnership by providing specialists with vast experience in supporting patients of all ages and disease processes on ECMO. Founded in May of 2007, ECMO Advantage provides extracorporeal related consulting, training, staffing and equipment rental nationwide. ECMO Advantage specialists are among the top professionals in the extracorporeal community and bring with them over 200 years combined experience in critical care and over 100 years combined experience in extracorporeal support. For more information, visit their website, www.ecmoadvantage.com.
“Many of our customers have requested the transport of patients requiring the support of this highly specialized treatment and equipment during the flight,” said AirMed Executive Vice President Denise Treadwell. “We are very pleased at this new relationship with ECMO Advantage, undoubtedly the leader in this field. This partnership will allow AirMed and ECMO Advantage to provide safe transport of these patients to recognized ECMO Centers around the nation while maintaining quality patient care."
In intensive care medicine, extracorporeal membrane oxygenation (ECMO) is an extracorporeal technique of providing both cardiac and respiratory support oxygen to patients whose heart and lungs are so severely diseased or damaged that they can no longer serve their function. An ECMO machine is similar to a heart/lung machine and is most commonly used in neonatal intensive-care units, for newborns in pulmonary distress, but it is also used for adults that, even with the use of a ventilator, need to be oxygenated until they are able to do the job with out assistance. One of the new uses is in adults with the H1N1 virus. ECMO treatment provides oxygenation until their lung function has sufficiently recovered to maintain appropriate O2 saturation.
About the air ambulance company AirMed International
AirMed International is the country’s leading air ambulance, chosen as exclusive air medical transport for the world-famous Mayo Clinic as well as a preferred carrier for the U.S. Department of Defense. AirMed is CAMTS and EURAMI accredited and operates a fleet of fully customized, fixed-wing aircraft, including the largest medical jet in the U.S., the Hawker 800. AirMed's six strategic bases of operations in Alabama, Hawaii, Minnesota, Ohio, and internationally in Beijing and Hong Kong, provide advantageous geographic coverage and rapid dispatch. AirMed International is the two-time recipient of the International Travel Insurance Journal’s “Air Ambulance of the Year,” and also created weatherturndown.com, an industry-wide website promoting air medical safety across the country. For more information, visit www.airmed.com or call 205-443-4880.
About ECMO Advantage
ECMO Advantage Corp brings a wealth of knowledge to the partnership by providing specialists with vast experience in supporting patients of all ages and disease processes on ECMO. Founded in May of 2007, ECMO Advantage provides extracorporeal related consulting, training, staffing and equipment rental nationwide. ECMO Advantage specialists are among the top professionals in the extracorporeal community and bring with them over 200 years combined experience in critical care and over 100 years combined experience in extracorporeal support. For more information, visit their website, www.ecmoadvantage.com.
